Tin tức & Cập nhật

In the treatment of patients with paroxysmal atrial fibrillation (AF), pulse field ablation (PFA) system appears to yield safety and efficacy outcomes that are noninferior to those of conventional thermal ablation, according to data from the ADVENT trial.

Dietary eicosapentaenoic acid/docosahexaenoic acid/docosapentaenoic acid (EPA/DHA/DPA) does not seem to increase the risk of atrial fibrillation (AF) but even shows an inverse association with AF in a nonlinear manner, according to a study.

Circulating microRNAs (miRNAs) have been observed in patients with severe functional tricuspid regurgitation (FTR), reveals a study presented at ESC 2023.

Patients with atrial high-rate episodes (AHRE) do not seem to benefit from anticoagulation with edoxaban, which has fallen short of reducing the composite outcome of stroke, systemic embolism, or cardiovascular death, according to the results of the NOAH-AFNET* 6 trial.

The updated cardiovascular disease (CVD) prediction algorithm SCORE2 can be used to estimate the 10-year CVD risk in individuals without diabetes or CVD in the Asia Pacific/Middle East region, according to a study presented at ESC 2023.

Monotherapy with recaticimab can significantly lower low-density lipoprotein cholesterol (LDL-C) levels in patients with nonfamilial hypercholesterolemia (non-FH) and mixed hyperlipidaemia, according to data from the phase III REMAIN-1 study presented at ESC 2023.

For individuals with type 2 diabetes, leading a healthy lifestyle and scoring high on the American Heart Association (AHA)’s Life's Essential 8 (LE8) metric can lead to lower risks of developing macrovascular and microvascular diseases, as shown in a study.